CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice
Article in Molecular Therapy — Methods & Clinical Development (January 2022)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in Molecular Therapy — Methods & Clinical Development (January 2022)
Preprint in bioRxiv (June 2021)
Book chapter (February 2021)